Werewolf Therapeutics, Inc. 8-K

What Happened
Werewolf Therapeutics, Inc. (HOWL) filed a Form 8-K on March 27, 2026 (Item 2.02) to announce its financial results for the quarter ended December 31, 2025. The company issued a press release reporting those quarterly results, which the 8-K furnishes as Exhibit 99.1.

Key Details

• Press release announcing quarterly financial results issued and furnished on March 27, 2026 (Exhibit 99.1).
• Financial period covered: quarter ended December 31, 2025.
• Filing includes an Inline XBRL cover page (Exhibit 104).
• Form 8-K signed by Michael Urban, Vice President of Finance and Corporate Controller.

Why It Matters
This 8-K signals that Werewolf has publicly reported its latest quarterly results; investors should review the attached press release and any related filings for specifics on revenue, expenses, cash runway, and operational updates. The filing also includes a standard cautionary note on forward-looking statements, meaning projections or plans disclosed in the release are subject to risks and may change.